Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)


Because of the medicine is one of the indispensable strategic commodities and on the events, the world is witnessing from the outbreak of the new Corona epidemic (Covid-19) and the Egyptian policy directions to combat and contain this epidemic in parallel with the economic process, the Egyptian International Pharmaceutical Industries (EIPICO) has formed a committee headed by the HSE Manager to manage and develop appropriate decisions to face the crisis and the committee has taken a set of measures that would prevent the spread of the Coronavirus.


COVID-19 Related Products 

>> EIPICO follows a customer-driven marketing strategy.

>> That’s why EIPICO is keen on satisfying customer needs especially in times of crisis.

>> EIPICO produces many products involved in COVID-19 management regimen:



EPIZITHRO




Product Brief:

 ►A broad-spectrum antibiotic.  ►It belongs to the macrolide class. ►It offers the convenience of once-daily dosing.

Read more





EPICEPHIN



Product Brief:

►A broad-spectrum antibiotic. ►It belongs to the 3rd generation cephalosporin class. ►It offers the convenience of once-daily dosing.

Read more





CETAL


Product Brief:

 ►An Analgesic/Antipyretic. ► It offers a high safety profile.

Read more





DEXAMETHASONE SODIUM PHOSPHATE USP



Product Brief:

 ►Dexamethasone Sodium Phosphate USP is a corticosteroid.

Read more





HYDROCORTISONE SODIUM SUCCINATE



Product Brief:

 ►Hydrocortisone Sodium Succinate is a corticosteroid.

Read more





CEVITIL


Product Brief:

 ►Vitamin-C Supplement.

Read more





FERROFOVIT - Z 


Product Brief:

 ►FERROFOL VIT- Z is multivitamins and minerals preparation.

Read more





WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1331101